| Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1519 | 2017 |
| Early detection of pancreatic cancer: opportunities and challenges AD Singhi, EJ Koay, ST Chari, A Maitra Gastroenterology 156 (7), 2024-2040, 2019 | 571 | 2019 |
| β-catenin activation promotes immune escape and resistance to anti–PD-1 therapy in hepatocellular carcinoma M Ruiz de Galarreta, E Bresnahan, P Molina-Sánchez, KE Lindblad, ... Cancer discovery 9 (8), 1124-1141, 2019 | 569 | 2019 |
| Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a … AD Singhi, WH Westra Cancer 116 (9), 2166-2173, 2010 | 534 | 2010 |
| Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 527 | 2017 |
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ... Gastroenterology 149 (6), 1501-1510, 2015 | 440 | 2015 |
| Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia AD Singhi, K McGrath, RE Brand, A Khalid, HJ Zeh, JS Chennat, ... Gut 67 (12), 2131-2141, 2018 | 337 | 2018 |
| Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression V Bernard, A Semaan, J Huang, FA San Lucas, FC Mulu, BM Stephens, ... Clinical Cancer Research 25 (7), 2194-2205, 2019 | 300 | 2019 |
| A mechanistic classification of clinical phenotypes in neuroblastoma S Ackermann, M Cartolano, B Hero, A Welte, Y Kahlert, A Roderwieser, ... Science 362 (6419), 1165-1170, 2018 | 269 | 2018 |
| Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers AD Singhi, B George, JR Greenbowe, J Chung, J Suh, A Maitra, ... Gastroenterology 156 (8), 2242-2253. e4, 2019 | 266 | 2019 |
| Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3 JT Patton, LD Mayo, AD Singhi, AV Gudkov, GR Stark, MW Jackson Cancer research 66 (6), 3169-3176, 2006 | 234 | 2006 |
| Safety and biologic response of pre-operative autophagy inhibition in combination with gemcitabine in patients with pancreatic adenocarcinoma BA Boone, N Bahary, AH Zureikat, AJ Moser, DP Normolle, WC Wu, ... Annals of surgical oncology 22, 4402-4410, 2015 | 223 | 2015 |
| Alternative lengthening of telomeres and loss of DAXX/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors AD Singhi, TC Liu, JL Roncaioli, D Cao, HJ Zeh, AH Zureikat, A Tsung, ... Clinical Cancer Research 23 (2), 600-609, 2017 | 202 | 2017 |
| Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts AD Singhi, MN Nikiforova, KE Fasanella, KM McGrath, RK Pai, NP Ohori, ... Clinical Cancer Research 20 (16), 4381-4389, 2014 | 199 | 2014 |
| A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram TA Ellison, CL Wolfgang, C Shi, JL Cameron, P Murakami, LJ Mun, ... Annals of surgery 259 (2), 204-212, 2014 | 173 | 2014 |
| American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with … AD Singhi, HJ Zeh, RE Brand, MN Nikiforova, JS Chennat, KE Fasanella, ... Gastrointestinal endoscopy 83 (6), 1107-1117. e2, 2016 | 171 | 2016 |
| Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma BA Boone, J Steve, MS Zenati, ME Hogg, AD Singhi, DL Bartlett, ... Annals of surgical oncology 21, 4351-4358, 2014 | 164 | 2014 |
| Programmed death-ligand 1 expression is common in gastric cancer associated with Epstein-Barr virus or microsatellite instability C Ma, K Patel, AD Singhi, B Ren, B Zhu, F Shaikh, W Sun The American journal of surgical pathology 40 (11), 1496-1506, 2016 | 162 | 2016 |
| The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer BA Boone, L Orlichenko, NE Schapiro, P Loughran, GC Gianfrate, JT Ellis, ... Cancer gene therapy 22 (6), 326-334, 2015 | 161 | 2015 |
| A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients HJ Zeh, N Bahary, BA Boone, AD Singhi, JL Miller-Ocuin, DP Normolle, ... Clinical cancer research 26 (13), 3126-3134, 2020 | 159 | 2020 |
